Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors

…, DK Holm, SG Sækmose, AC Nilsson… - Clinical Infectious …, 2021 - academic.oup.com
Background The pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has tremendous consequences for our societies. Knowledge of the seroprevalence …

[PDF][PDF] Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer

S Ehmsen, A Asmussen, SS Jeppesen, AC Nilsson… - Cancer cell, 2021 - cell.com
Patients with solid and hematologic cancer are more vulnerable to SARS-CoV-2 infection
and have poorer prognoses of COVID-19 because of their general health status, …

[HTML][HTML] Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis

F Novak, AC Nilsson, C Nielsen, DK Holm… - Multiple sclerosis and …, 2021 - Elsevier
… Author links open overlay panel Frederik Novak a b , Anna Christine Nilsson c d , Christian
Nielsen c d , Dorte K. Holm c , Kamilla Østergaard e , Anna Bystrup f , Keld-Erik Byg d g , Isik S…

[HTML][HTML] Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use

AC Nilsson, DK Holm, US Justesen… - International Journal of …, 2021 - Elsevier
Objectives Evaluate six commercial serological assays for detection of IgA, IgM or IgG SARS-CoV-2
antibodies in different disease severities. Methods Three lateral flow tests (LFTs) (…

Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients

IK Holden, C Bistrup, AC Nilsson… - Journal of Internal …, 2021 - Wiley Online Library
Background It is currently not well described if a two‐dose regimen of a Covid‐19 vaccine is
sufficient to elicit an immune response in solid organ transplant (SOT) recipients. Results A …

[PDF][PDF] Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination

S Ehmsen, A Asmussen, SS Jeppesen, AC Nilsson… - Cancer Cell, 2022 - cell.com
Patients with cancer are at risk of severe COVID-19 disease due to immunosuppression
caused by cancer and/or cancer therapies (Ehmsen et al., 2021b; Tian et al., 2020). We and …

Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark

…, DK Holm, AC Nilsson… - The Journal of …, 2022 - academic.oup.com
Background Studies presenting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection fatality rate (IFR) for healthy individuals are warranted. We estimate IFR by …

[HTML][HTML] Determinants of antibody response to a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients: Results from the prospective cohort study …

D Balsby, AC Nilsson, S Möller, SO Lindvig… - Vaccines, 2022 - mdpi.com
Background: We studied factors related to humoral response in solid organ transplant (SOT)
recipients following a three-dose regimen of an mRNA-based SARS-CoV-2 vaccine. Method…

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis

MN Olesen, A Wuolikainen, AC Nilsson… - Neurology …, 2020 - AAN Enterprises
Objective To investigate inflammatory cytokines in patients with motor neuron disease (MND)
evaluating the putative contribution of amyotrophic lateral sclerosis (ALS)-causing gene …

NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study

MS Nissen, MS Ørvik, AC Nilsson, M Ryding… - Journal of …, 2022 - Springer
Background To describe the national Danish N-methyl-d-aspartate receptor encephalitis (NMDARE)
cohort. Methods All NMDAR immunoglobulin G (IgG) positive cases in Denmark …